fbpx Targeting LCMT1-mediated neuroprotective mechanisms in Alzheimer disease | HMRI

Alzheimer’s disease is characterized by the accumulation of proteins known as amyloid-beta and tau in the brain. This grant will investigate therapeutic approaches that target the amyloid-beta and tau accumulation in the brain with the hope of finding effective drugs for the treatment of Alzheimer’s disease into the future.

Research Area 
Project type 
Project Grant
Year of funding 
2016